Her 2 Testing in Indian Patients With Gastric Cancer
关键词
抽象
描述
1. Study Objective/ Aims Aim: - Rate of Her 2 positivity in 100 consecutive gastric cancer patients Primary Objective
Test for Her 2 in 100 consecutive gastric cancer patients Immuno-histochemistry will be done in all patients. Patients with 2 and 3+ IHC will also have FISH done.
2. Study Design& Methodology
Patients will have the Her2 tested in 100 consecutive gastric cancer samples by immunohistochemistry and patients with 2+ and 3+ result will also have FISH done. This will not affect patient management
3. Overview of Data collection Dr.Bhawna Sirohi the principal investigators will maintain and supervise data collection and maintaining records. The patient will be de-identified.
4. Selection of Study Population
Inclusion Criteria:
100 consecutive patients with gastric cancer who have a pathology specimen at TMH
Exclusion Criteria:
If histopathology blocks were not available
5) Sample size 100 to be enrolled. Patient consent waiver applied for as this does not affect patient care 6) Statistical Analysis It is an Observational study so Results will be given as %age of total population.
日期
| 最后验证: | 03/31/2017 |
| 首次提交: | 02/26/2013 |
| 提交的预估入学人数: | 03/17/2013 |
| 首次发布: | 03/18/2013 |
| 上次提交的更新: | 04/24/2017 |
| 最近更新发布: | 04/26/2017 |
| 实际学习开始日期: | 05/31/2013 |
| 预计主要完成日期: | 01/31/2017 |
| 预计完成日期: | 01/31/2017 |
状况或疾病
相
资格标准
| 有资格学习的年龄 | 18 Years 至 18 Years |
| 有资格学习的性别 | All |
| 取样方式 | Non-Probability Sample |
| 接受健康志愿者 | 是 |
| 标准 | Inclusion Criteria: - 100 consecutive patients with gastric cancer who have a pathology specimen at TMH Exclusion Criteria: - If histopathology blocks were not available |
结果
主要结果指标
1. Incidence of Her2 testing in Gastric cancer [6 month]
